Total Liabilities: The total value of all possible claims against the corporation.
Coherus Oncology, Inc. (CHRS) had Total Liabilities of $428.75M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.57M |
|
$-35.53M |
|
$3.72M |
|
$7.85M |
|
$55.90M |
|
$-44.33M |
|
$-0.18M |
|
$-44.52M |
|
$-44.52M |
|
$-44.52M |
|
$-44.52M |
|
$-35.53M |
|
$-44.52M |
|
$-44.33M |
|
$-43.37M |
|
116.23M |
|
116.23M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$460.95M |
|
$1.63M |
|
$55.56M |
|
$516.52M |
|
$372.30M |
|
$36.96M |
|
$56.45M |
|
|
Total Liabilities |
$428.75M |
$87.77M |
|
$38.29M |
|
$87.77M |
|
116.24M |
|
| Cash Flow Statement Financials | |
$-118.80M |
|
$377.93M |
|
$-281.79M |
|
$126.25M |
|
$103.59M |
|
$-22.66M |
|
$14.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.24 |
|
-- |
|
-- |
|
0.30 |
|
0.42 |
|
67.84% |
|
-383.14% |
|
-383.14% |
|
-- |
|
-384.73% |
|
-307.07% |
|
$-118.80M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
1.82 |
|
0.05 |
|
1948.37 |
|
-50.72% |
|
-116.26% |
|
-8.62% |
|
-35.69% |
|
$0.76 |
|
$-1.02 |
|
$-1.02 |
|